Literature DB >> 22171235

Mental illness that is difficult to classify: a case study.

Artemis Igoumenou1, Maria G Turri, Raana Din, Harvey Gordon.   

Abstract

A case is presented of a man who has been detained in secure psychiatric hospitals for the majority of his life. Although his index offence was minor he has a long history of violence. The patient has collected a vast number of diagnoses over the years. His treatment demonstrates a role for clozapine in ameliorating violent behaviour and aggression. We conceptualise this as being linked to the properties of this drug. From the patient's history we believe that reserpine may have had a similar effect to clozapine regarding mental state and reduction of violent behaviour. This case illustrates the consequences of inaccurate diagnosis and therefore the provision of adequate treatment. It highlights that the continuity of care and the communication of information is essential for the patient's quality of life. It also illustrates how the use of certain antipsychotics may prove essential in the control of violence so that institutionalisation can be prevented.

Entities:  

Year:  2009        PMID: 22171235      PMCID: PMC3029562          DOI: 10.1136/bcr.04.2009.1736

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Metabolism of norepinephrine-H3 released by tyramine and reserpine.

Authors:  I J KOPIN; E K GORDON
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

Authors:  E D FREIS
Journal:  N Engl J Med       Date:  1954-12-16       Impact factor: 91.245

3.  Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Authors:  Menahem I Krakowski; Pal Czobor; Leslie Citrome; Nigel Bark; Thomas B Cooper
Journal:  Arch Gen Psychiatry       Date:  2006-06

Review 4.  Depressive reactions associated with reserpine.

Authors:  S V Ambrosino
Journal:  N Y State J Med       Date:  1974-05

5.  Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.

Authors:  N E Andén; U Strömbom; T H Svensson
Journal:  Psychopharmacologia       Date:  1973

6.  A reappraisal of the interaction between tricyclic antidepressants and reserpine-like drugs.

Authors:  P Willner; D Clark
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

7.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

8.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Authors:  M Chakos; J Lieberman; E Hoffman; D Bradford; B Sheitman
Journal:  Am J Psychiatry       Date:  2001-04       Impact factor: 18.112

9.  Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Authors:  Jean-Pierre Lindenmayer; Pal Czobor; Jan Volavka; Jeffrey A Lieberman; Leslie Citrome; Brian Sheitman; Joseph P McEvoy; Thomas B Cooper; Miranda Chakos
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

Review 10.  Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination.

Authors:  Joanna Moncrieff
Journal:  Br J Psychiatry       Date:  2003-08       Impact factor: 9.319

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.